Coronary Arteriosclerosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-01-26
Clinical Trial Update: The IDEAL-PCI Extended Registry [Phase 4]
The IDEAL-PCI Extended Registry trial (Phase 4) has been withdrawn.